392 related articles for article (PubMed ID: 35120338)
1. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
2. Exhaled volatile organic compounds detect pulmonary exacerbations early in children with cystic fibrosis: results of a 1 year observational pilot study.
van Horck M; Smolinska A; Wesseling G; de Winter-de Groot K; de Vreede I; Winkens B; Jöbsis Q; Dallinga J; Dompeling E; van Schooten FJ
J Breath Res; 2021 Feb; 15(2):026012. PubMed ID: 33630756
[TBL] [Abstract][Full Text] [Related]
3. Methods to Detect Volatile Organic Compounds for Breath Biopsy Using Solid-Phase Microextraction and Gas Chromatography-Mass Spectrometry.
Schulz E; Woollam M; Grocki P; Davis MD; Agarwal M
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299010
[TBL] [Abstract][Full Text] [Related]
4. A rapid method for breath analysis in cystic fibrosis patients.
Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
[TBL] [Abstract][Full Text] [Related]
5. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
[TBL] [Abstract][Full Text] [Related]
6. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls.
Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M
J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137
[TBL] [Abstract][Full Text] [Related]
7. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
8. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
[TBL] [Abstract][Full Text] [Related]
9. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
[TBL] [Abstract][Full Text] [Related]
11. Impact of breath sample collection method and length of storage of breath samples in Tedlar bags on the level of selected volatiles assessed using gas chromatography-ion mobility spectrometry (GC-IMS).
Czippelová B; Nováková S; Šarlinová M; Baranovičová E; Urbanová A; Turianiková Z; Krohová JČ; Halašová E; Škovierová H
J Breath Res; 2024 May; 18(3):. PubMed ID: 38701772
[TBL] [Abstract][Full Text] [Related]
12. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Smith D; Španěl P
J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.
van de Kant KD; van der Sande LJ; Jöbsis Q; van Schayck OC; Dompeling E
Respir Res; 2012 Dec; 13(1):117. PubMed ID: 23259710
[TBL] [Abstract][Full Text] [Related]
15. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis.
Licht JC; Seidl E; Slingers G; Waters V; de Vries R; Post M; Ratjen F; Grasemann H
J Cyst Fibros; 2023 Sep; 22(5):888-893. PubMed ID: 36849333
[TBL] [Abstract][Full Text] [Related]
16. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects.
Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H
Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041
[TBL] [Abstract][Full Text] [Related]
17. Oxidative Stress Biomarkers in Exhaled Breath of Workers Exposed to Crystalline Silica Dust by SPME-GC-MS.
Jalali M; Zare Sakhvidi MJ; Bahrami A; Berijani N; Mahjub H
J Res Health Sci; 2016; 16(3):153-161. PubMed ID: 27840344
[TBL] [Abstract][Full Text] [Related]
18. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
19. Can exhaled volatile organic compounds predict asthma exacerbations in children?
van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
[TBL] [Abstract][Full Text] [Related]
20. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
